Evidence map›Paper›PMID 24446548›Full record

Trial reportPsychiatry research2013

fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.

Jeffrey Morris Miller, Noam Schneck, Greg J Siegle, Yakuan Chen, R Todd Ogden, Toshiaki Kikuchi, Maria A Oquendo, J John Mann, Ramin V Parsey

Erratum issuedAbstract readClinical Trial
In one paragraph

Trial report in Psychiatry research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex.The international journal of neuropsychopharmacology · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Emotion Regulatory Brain Function and SSRI Treatment in PTSD: Neural Correlates and Predictors of Change.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Jeffrey Morris Miller
Noam Schneck
Greg J Siegle
Yakuan Chen
R Todd Ogden
Toshiaki Kikuchi
Maria A Oquendo
J John Mann
Ramin V Parsey
New York State Psychiatric InstituteColumbia University · USFairleigh Dickinson University · USNew York Psychoanalytic Society and Institute · USStony Brook University · USUniversity of Pittsburgh · US

Funding

Research Training in Mood and Anxiety Disorders: From Animal Models to PatientsT32MH015144 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Eduardo David Leonardo · 1985 to 2026
$11.1M
Biological Predictors of Response to AntidepressantsR01MH074813 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PARSEY, RAMIN V. · 2006 to 2010
$2.3M
NIMH NIH HHS R01 MH074813NIMH NIH HHS R01MH074813NIMH NIH HHS T32 MH015144
6 · The paper itself

Abstract

Clinically useful predictors of treatment outcome in major depressive disorder (MDD) remain elusive. We examined associations between functional magnetic resonance imaging (fMRI) blood oxygen level dependent (BOLD) signal during active negative word processing and subsequent selective serotonin reuptake inhibitor (SSRI) treatment outcome in MDD. Unmedicated MDD subjects (n=17) performed an emotional word processing fMRI task, and then received eight weeks of standardized antidepressant treatment with escitalopram. Lower pre-treatment BOLD responses to negative words in midbrain, dorsolateral prefrontal cortex, paracingulate, anterior cingulate, thalamus and caudate nuclei correlated significantly with greater improvement following escitalopram treatment. Activation of these regions in response to negative words correlated significantly with reaction time for rating word relevance. Maximally predictive clusters of voxels identified using a cross-validation approach predicted 48% of the variance in response to treatment. This study provides preliminary evidence that SSRIs may be most beneficial in patients who are less able to engage cognitive control networks while processing negative stimuli. Differences between these findings and previous fMRI studies of SSRI treatment outcome may relate to differences in task design. Regional BOLD responses to negative words predictive of SSRI outcome in this study were both overlapping and distinct from those predictive of outcome with cognitive behavioral therapy (CBT) in previous studies using the same task. Future studies may examine prediction of differential outcome across treatments in the context of a randomized controlled trial.

Indexed as

EmotionsLanguageAdolescentAdultAntidepressive AgentsBrainCitalopramFemaleHumansMagnetic Resonance ImagingMajor Depressive DisorderMaleMiddle AgedNeuroimagingReaction TimeReproducibility of ResultsAntidepressive AgentsCitalopramSelective Serotonin Reuptake Inhibitors

Identifiers

PMID24446548
PMCPMC4083855
OpenAlexW2159717654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.